Effects of acupuncture on outcome of in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) in women with polycystic ovarian

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201011275181N4

Enrollment

Registered

2011-04-13

Start date

2009-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Infertility. Female infertility associated with anovulation

Interventions

Control group: (Placebo ) the same needles are used in 5 sessions of thirthy minutes.

Intervention 1: Intervention group : Accuponcture based on Traditional Chinese Medicine, 5 sessins of thirthy minutes. Intervention 2: Control group: (Placebo ) the same needles are used in 5 sess

Treatment - Other

Placebo

Intervention group : Accuponcture based on Traditional Chinese Medicine, 5 sessins of thirthy minutes.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: women with the diagnosis of PCO (Rotterdam criteria) admitted to the clinic for IVF or ICSI treatments of infertility . Exclusion criteria: Patients who had uncontrolled systemic disorders, ovum or embryo donor, other infertility factors exception PCO, and who for personal reasons did not want to participate further were excluded from the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Oocyte Methaphase 2. Timepoint: before and after embryo transfer. Method of measurement: diagnosed by Embryologist and with embryological criteria.;Embryo quality. Timepoint: 2 days after embryo transfer. Method of measurement: diagnosed by Embryologist and with embryological criteria.;Oocyte Fertilization rate. Timepoint: first day after embryo transfer. Method of measurement: diagnosed by Embryologist and with embryological criteria.	—

Measure

Time frame

Oocyte Methaphase 2. Timepoint: before and after embryo transfer. Method of measurement: diagnosed by Embryologist and with embryological criteria.;Embryo quality. Timepoint: 2 days after embryo transfer. Method of measurement: diagnosed by Embryologist and with embryological criteria.;Oocyte Fertilization rate. Timepoint: first day after embryo transfer. Method of measurement: diagnosed by Embryologist and with embryological criteria.

—

Secondary

Measure	Time frame
Take home baby. Timepoint: 9 months after Embryo transfer. Method of measurement: Delivery.;Biochemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: B-hcg.;Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: sac observed in vaginal Sonography.;Miscarriage. Timepoint: <12 weeks after embryo transfer. Method of measurement: vaginal sonography.	—

Measure

Time frame

Take home baby. Timepoint: 9 months after Embryo transfer. Method of measurement: Delivery.;Biochemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: B-hcg.;Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: sac observed in vaginal Sonography.;Miscarriage. Timepoint: <12 weeks after embryo transfer. Method of measurement: vaginal sonography.

—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026